These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19545653)

  • 1. Forty years of publication of transplantation proceedings--the second decade: the cyclosporine revolution.
    Kahan BD
    Transplant Proc; 2009 Jun; 41(5):1423-37. PubMed ID: 19545653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forty years of publication of transplantation proceedings-the third decade: the expansion of the enterprise.
    Kahan BD
    Transplant Proc; 2009 Dec; 41(10):3975-4020. PubMed ID: 20005335
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy with monoclonal antibodies to CD4: potential not appreciated?
    Hall BM
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):71-7. PubMed ID: 2573271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
    Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ruby anniversary: forty years of publication of Transplantation Proceedings - the first decade: the flowering of immunology and immunogenetics.
    Kahan BD
    Transplant Proc; 2009; 41(1):5-10. PubMed ID: 19249461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beginning of clinical tolerance in solid organ allografts.
    Monaco AP
    Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of solid organ transplantation and organ donation.
    Linden PK
    Crit Care Clin; 2009 Jan; 25(1):165-84, ix. PubMed ID: 19268801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
    Kahan BD
    Transplant Proc; 2008 Dec; 40(10 Suppl):S17-20. PubMed ID: 19100899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era.
    Thorsby E; Pfeffer P; Leivestad T
    Transplant Proc; 2004 Mar; 36(2 Suppl):16S-21S. PubMed ID: 15041301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG; Gutmann T; Daar AS
    Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with cyclosporine in heart transplantation.
    Sivathasan C
    Transplant Proc; 2004 Mar; 36(2 Suppl):346S-348S. PubMed ID: 15041365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine: 20 years of experience at the University of Munich.
    Graeb C; Arbogast H; Guba M; Jauch KW; Land W
    Transplant Proc; 2004 Mar; 36(2 Suppl):125S-129S. PubMed ID: 15041321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Desensitization protocols in immunized living donor kidney transplant recipients].
    Nocera A
    G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
    Fan Y; Xiao YB; Weng YG
    Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifty years in the vineyard of transplantation: looking back.
    Kahan BD
    Transplant Proc; 2011 Oct; 43(8):2853-9. PubMed ID: 21996173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients.
    Lin YX; Wang LL; Yan LN; Cai P; Li B; Wen TF; Zeng Y
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):241-6. PubMed ID: 19502162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunobiology of transplantation.
    Brent LB
    Int Surg; 1999; 84(4):275-8. PubMed ID: 10667805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.